Following the successful launch of the LapAR™ platform in 2020 and having positioned itself as the market leader for surgical training technologies in the United Kingdom, Inovus raised a $7million scale up round in 2022. The investment will be utilised to expand direct commercial operations across North America and accelerate new product development. The round was led by a majority investment from Norgine Ventures. 

Norgine Ventures is backed by Norgine, a private, European healthcare company with 116 years of experience in the pharma space. Norgine Ventures was started in 2012 to diversify Norgine’s activities and foster innovation in the healthcare sector. Norgine Ventures provides debt and debt-like financing to innovative, fast-growing companies in the fields of healthcare and life sciences, in Europe and the US. To date, Norgine Ventures has invested in over twenty businesses, including specialty pharma, diagnostic and medical device companies, at various stages of their life cycle. For further information: